Approval · Notice of Compliance 14485 · 2013
OFIRMEV: Notice of Compliance 14485
Issued June 20, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14485
- Date
- June 20, 2013
- Company
- Cadence Pharmaceuticals Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Analgesic an antipyretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OFIRMEV | 02408066 | Cancelled Pre Market |
Medicinal ingredients
- ACETAMINOPHEN 10 MG per ML